Royalty Pharma PLC
13F holders, Q1 2024 (March 31)1holders
$30.37avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Royalty Pharma PLC in their 13F filings. The largest holder was DNB Asset Management AS ($1.7M).
- Company
- Royalty Pharma PLC
- CUSIP
- 00BMVP7Y0
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| DNB Asset Management AS | 0.01% | Reduce -43.2% | 57,275 | $1.7M |
"% of holder's portfolio" is Royalty Pharma PLC's weight in each manager's 13F, not the share of Royalty Pharma PLC the manager owns.